Veloxis Pharmaceuticals, Inc NDCs and Package Codes
This page lists NDC package records associated with labeler code 68992 (Veloxis Pharmaceuticals, Inc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
6
Package NDCs
3
Products
3
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
2
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Envarsus XR Tacrolimus .75 mg/1 TABLET, EXTENDED RELEASE | 68992-3075-01 | — | On market | View → |
| Envarsus XR Tacrolimus 1 mg/1 TABLET, EXTENDED RELEASE | 68992-3010-01 | $5.981 /unit · NADAC | On market | View → |
| Envarsus XR Tacrolimus 4 mg/1 TABLET, EXTENDED RELEASE | 68992-3040-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.